Sara Pellegrino | Senior Vice President, Investor Relations and Corporate Communications |
Fred Vogt | Interim President and Chief Executive Officer |
Igor Bilinsky | Chief Operating Officer |
Jim Ziegler | Executive Vice President, Commercial |
Friedrich Finckenstein | Chief Medical Officer |
Jean-Marc Bellemin | Chief Financial Officer |
Michael Yee | Jefferies |
Peter Lawson | Barclays |
Colleen Kusy | Baird |
Reni Benjamin | JMP Securities |
Mark Breidenbach | Oppenheimer |
Mara Goldstein | Mizuho |
Madhu Kumar | Goldman Sachs |
Hello and thank you for standing by. My name is Andrew and I will be your conference operator today. At this time I would like to welcome everyone to the Iovance Biotherapeutics First Quarter 2023 Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session.